Skip to product information
1 of 1

Molteni Farmaceutici

Luan Gel 1% 100 g gel

Luan Gel 1% 100 g gel

Regular price €11,06
Regular price €11,06 Sale price €11,06
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

100g

EAN

005638022

MINSAN

005638022

View full details

In ottemperanza all'articolo 118 “autorizzazione della pubblicità presso il pubblico” del decreto legislativo 24 aprile 2006, numero 219

INDICATIONS

• LUAN 2.5% gel: Facilitates endourethral maneuvers (introduction of catheters, dilations, cystoscopies, etc.) by combining the lubricating and anesthetic action. • LUAN 1% gel: Esophagoscopic intubations and for curative anesthesia, pharyngoscopies, tracheo-bronchoscopies, gastroscopies and rectoscopies, and in all endoscopic indications of an exploratory and curative nature. The product, combining the lubricating action with the anesthetic action, allows spastic reactions and reflexes starting from the mucous membranes with which the instruments come into contact during endoscopic maneuvers to be avoided.

 

ACTIVE INGREDIENTS

LUAN 2.5% gel 100 g contain: Lidocaine hydrochloride 2.5 g Excipients: methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, propyl p-hydroxybenzoate, sodium benzoate For the full list of excipients, see section 6.1 LUAN 1% gel 100 g contain: Lidocaine hydrochloride 1 g Excipients: methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, propyl p-hydroxybenzoate, sodium benzoate For the full list of excipients, see section 6.1

 

EXCIPIENTS

LUAN 2.5% gel Excipients: carmellose sodium, glycerol, methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, propyl p-hydroxybenzoate, sodium benzoate, purified water. LUAN 1% gel Excipients: carmellose sodium, glycerol, methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, propyl p-hydroxybenzoate, sodium benzoate, purified water.

 

CONTRAINDICATIONS AND SIDE EFFECTS

Hypersensitivity to amide-type local anesthetics or to any of the excipients.

 

DOSAGE

LUAN 2.5% gel Push the ointment directly into the urethra by squeezing the tube and at the same time massaging the posterior urethra, applying urethral forceps for 10 minutes, after which you can practice the desired endourethral maneuvers. The contents of the tube are sufficient to completely fill the urethra. In order to facilitate the introduction of the medicine and to eliminate the pain that can be caused by the contact of the metal tip of the tube with particularly painful parts, the package is accompanied by a plastic extension to be screwed onto the tube itself at the time of use. LUAN 1% gel Carefully spread a layer of product on the instrument before introducing it. The neutrality of the vehicle of both formulations of the product, its complete solubility in water and the absence of fatty substances mean that, even with continued use of LUAN, the lenses of the instruments used for various types of intubations do not fog up and their rubber parts do not deteriorate. LUAN should be used with caution in patients who have severely damaged mucous membranes and sepsis in the region on which the application is to be made. Use caution in children, the elderly and seriously ill patients (see also section 4.4 Special warnings and precautions for use).

 

CONSERVATION

This medicinal product does not require any special storage conditions.

 

WARNINGS

The effectiveness and safety of lidocaine depend on correct dosage and application technique. It is therefore necessary to use the minimum quantity of the preparation sufficient to obtain the desired effect and avoid application for very prolonged periods. LUAN must be used with caution in patients with severely damaged mucous membranes or the site of inflammatory processes or sepsis in the region in which the application is to be carried out as there could be excessive absorption of the active ingredient. High absorption of lidocaine can cause serious reactions in the CNS. and the cardiovascular system in particular in children, the elderly and debilitated subjects (see paragraph 4.2). Products for topical application, especially if used for a long time or repeatedly, can give rise to sensitization phenomena. In this case it is necessary to interrupt the treatment and institute suitable therapy. Information on some excipients of LUAN The medicine contains sodium benzoate: it can be slightly irritating to the skin, eyes and mucous membranes. The medicine contains parahydroxybenzoates: it can cause allergic reactions, even delayed ones.

 

INTERACTIONS

Propranolol prolongs the plasma half-life of lidocaine. Cimetidine may increase plasma levels of lidocaine.

 

SIDE EFFECTS

Locally, hypersensitivity reactions characterized by pain, burning and itching may occur. Systemic reactions are generally rare. However, hypersensitivity reactions up to anaphylactic shock may occur. In the presence of irritated or damaged skin, the risk of systemic absorption and toxicity increases. The treatment of large areas and/or the use of high doses or the increase in body temperature may increase the risk of systemic absorption and a potential increase in toxicity. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

 

OVERDOSE

Symptoms of overdose (absolute or relative) are characterized by neuroexcitatory manifestations (tremors, convulsions followed by depression, respiratory failure and coma) and by cardiovascular alterations with hypotension and bradycardia. Treatment is symptomatic. Any seizures can be controlled with the administration of barbiturates or short-acting benzodiazepines.

 

PREGNANCY AND BREASTFEEDING

Studies on rats and rabbits have not highlighted any risks to the fetus. However, its safety in humans has not been established. This should be kept in mind before administration to pregnant women, particularly in the early stages. Since lidocaine is distributed in breast milk, the use of topical preparations, especially if applied to the tracheobronchial mucosa, must be used with caution in breastfeeding women.

 

EFFECTS ON DRIVING ABILITY

LUAN does not affect the ability to drive or use machines.

1 of 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.